The Coriell Institute for Medical Research is a not - for - profit research organization «dedicated to
understanding human genetic diseases and providing the highest quality genetic resources».
Not exact matches
To better
understand their findings, the team examined the animal model for APS1 (i.e. mice with the same
genetic defect as
human patients with the syndrome) and found that male mice spontaneously developed an inflammatory
disease in their prostate glands — a so - called prostatitis — and reacted to transglutaminase 4.
Although researchers do not yet know the biological significance of these discoveries, they say that fully cataloguing the genome may help them
understand how
genetic variations affect the risk of contracting
diseases such as cancer as well as how
humans grow from a single - celled embryo into an adult.
These observations and others have convinced the researchers that their CRISPR / Cas9 and hPSC system produces a stable, biologically accurate
human model for a common
genetic disease where new
understanding and new therapies are desperately needed.
New, sophisticated gene sequencing techniques are leading to an increasing
understanding of the causes of
genetic disease, and can help parents with affected children make informed reproductive choices, the annual conference of the European Society of
Human Genetics will hear.
«Thus, it is clear that further studies must investigate an increasingly complex matrix of cell types and conditions to fully
understand the role of
human genetic variation in
disease.»
The findings, published in the journal Nature, explain why the
human genome is so difficult to decipher — and contribute to the further
understanding of how
genetic differences affect the risk of developing
diseases on an individual level.
«We are analyzing massively large sets of
human genomic data to ultimately improve our
understanding of
genetic basis of
diseases.»
His research interests include the molecular underpinnings of cervical cancer (including developing
genetic screens), the identification of the
genetic determinants of quantitative traits in
humans, and the application of massively parallel sequencing technology for
understanding the genetics of complex
disease.
The start - up's mission is to
understand the nature of
human genetic variation and its impact on
human disease (medical genomics) and treatment (pharmacogenomics).
«Our findings also have important implications for mitochondrial
diseases in
humans, because this research significantly advances our
understanding of how mitochondrial DNA mutations affect individuals and populations, and provides a potential mechanism to explain how different
genetic variants may affect health,» Dr Rollins said.
Since this amoeba possesses an innate defense system similar to that of
humans, while being genetically modifiable, the researchers can therefore carry out experiments on it in order to
understand and fight
genetic diseases of the immune system.
«Comparing
human, chimpanzee and bonobo cells can give us clues to
understand biological processes, such as infection,
diseases, brain evolution, adaptation or
genetic diversity,» says senior research associate Iñigo Narvaiza, who led the study with senior staff scientist Carol Marchetto at the Salk Institute in La Jolla.
In the paper, the authors stressed that
understanding the
genetic makeup of these molluscs is important because many «freshwater snails are intermediate hosts for flatworm parasites and transmit infectious
diseases» to
humans and other animals.
We are at the initial stages of
understanding the
genetic basis of
human disease and evolution at all levels.
«This agreement is a part of deCODE's ongoing strategy to unleash the value of
human genetics,» said Kari Stefansson, founder and CEO of deCODE, «our research platform allows us to
understand the
genetic basis of
disease and modifiers of clinical phenotypes in actual patient populations; by doing so, we can rapidly move from targets to patient stratification and from there to companion diagnostics.»
Understanding the
genetic factors that regulate synaptic plasticity could point to new therapeutic approaches for
human diseases that disrupt synaptic connections.
The next phase in our scientific
understanding of
human health and
disease is to decipher the molecular basis of cell and tissue circuits and the impact of
genetic variations on these circuits.
The Center for Research on Genomics and Global Health (CRGGH) aims to facilitate a global
understanding of the relationship between
human genetic variation and population differences in
disease distribution, with the ultimate goal of informing health inequalities.
Understanding the
genetic basis of
human age - related
diseases, as well as normal aging, such as cardiovascular changes, age - related neurodegenerative
disease, autoimmune
disease, and diabetes constitutes an important step towards unraveling
disease pathogenesis and risk prediction.
The Swedish Genomes Program: For research projects with the aim to
understand genetic causes of
human disease, and which have a translational value and demonstrate potential significance for improving future healthcare in Sweden.
The phenotyping department of PHENOMIN - ICS is advancing a technical platform for functional characterization of preclinical models of
human diseases with respect to both
genetic understanding of pathophysiological mechanisms and the assessment of drug therapies.
She is interested in using and developing statistical methods to
understand the
genetic architecture of
human phenotypes and
diseases.
The Broad Institute is a joint venture that provides preeminent scientists with cutting - edge technologies in genomics and related disciplines in order to
understand human disease at the
genetic level.
This data sharing deepens our
understanding of variability in the
human genome and the
genetic underpinnings of
disease, leading to advances in genomics research and genomic medicine.
Having investigated the different representations of phenotypes, she applies this knowledge to data integration and
human genetic disorders with the aim of improving the
understanding about the molecular mechanisms underlying
human diseases.
Revolutionise scientific
understanding of the population biology of infectious
disease, by providing an unprecedented level of information about
genetic diversity, population structure, evolutionary selection, demography and gene flow, and by enabling this to be linked to information about the behaviour and migration patterns of
human and pathogen populations.
His research focuses on
understanding the role of
genetic variation in contributing to
human health and
disease using mouse models of
human disease, and more recently exploiting technologies developed for biomedical research for application in the field of
genetic pest management.
This centre has been devised as a space for excellence research in genomic medicine, focussing on the comprehensive study and
understanding of the
genetic basis of
human diseases in general, placing special emphasis on cancer and its
genetic disorders related to inheritance.
Feng's group is focusing first on conditions with the strongest
human genetic data, such as Huntington's
disease, in which a single gene causes a disorder, and using advanced neuroimaging technology and other tools to
understand how the mutation causes brain circuits to misfire.
«GTEx will begin to provide researchers with a comprehensive view of
genetic variation and a more precise
understanding of how it affects genes critical to the normal function of tissues and organs,» said NIH Director Francis S. Collins, M.D., Ph.D. «This resource will add a new dimension to our
understanding of
human biology and the mechanisms that lead to
disease.»
«The paper is also a powerful demonstration about how detailed
genetic studies can help us
understand human diseases.»
In fact, Ostrander, who works at the NHGRI's Cancer Genetics and Comparative Genomics Branch, was one of the lead authors of a white paper arguing for support to sequence the dog genome at a level of quality already available at the time for the mouse, «to better
understand the
genetic basis of complex
diseases affecting both
human and dog.»
The dog has already played an important role in emerging therapies for inherited blindness in
humans and similarities in
disease phenotype and eye structure and function between dog and man, together with the increasingly sophisticated
genetic tools that are available for the dog, mean that the dog is likely to play an ever increasing role in both our
understanding of the normal functioning of the eye and in our ability to treat inherited eye disorders.
(ref) The US government justified adding the dog and cat genome not for us veterinarians and pet lovers; they did it because
humans, dogs and cats have more
genetic diseases than any other animal species and
understanding and attempting to repair or prevent these
genetic issues in dogs and cats could have applications in
human medicine as well.
A leader in the
Human Genome Project, we are now focused on
understanding the role of genetics in health and
disease by using the latest genomic and
genetic techniques.
Rooted in a deepening
understanding of how brain architecture is shaped by the interactive effects of both
genetic predisposition and environmental influence, and how its developing circuitry affects a lifetime of learning, behavior, and health, advances in the biological sciences underscore the foundational importance of the early years and support an EBD framework for
understanding the evolution of
human health and
disease across the life span.